OpGen and Thermo Fisher Scientific have reached a supply agreement to commercialize OpGen's Acuitas Rapid Test for Pathogen ID in combination with Thermo Fisher's new mid-throughput real-time PCR system. OpGen disclosed no further terms of the deal, nor which Thermo Fisher system is part of the agreement.
OpGen reaches supply agreement with Thermo Fisher
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.